Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Prospective, Multicentric, Phase II Randomized Controlled Trial Comparing the Efficacy and Toxicity of Methotrexate to Cyclophosphamide in Large Granular Lymphocyte Leukemia: A French National Study (NCT01976182)

Thierry Lamy, Cedric Pastoret, Gandhi Damaj, Olivier Tournilhac, Emmanuel Bachy, Loic Ysebaert, Frederique Orsini Piocelle, Anne Banos, Marianne Schwarz, Estibaliz Lazaro, Pierre Feugier, Hugo Gonzalez, Alain Renault, Milena Kohn, Roch Houot, Mikael Roussel, Eric Bellissant

Blood (2024) 144 (Supplement 1): 979.

https://doi.org/10.1182/blood-2024-200266

Published: 2024

Journal Articles

Flow MRD Monitoring Combining Laip/Dfn and CD34+CD38- LSCs Is a Strong Predictor of Outcome in Adult AML Independently of the ELN-2022 Risk: First Results from the Multicentric Acute Leukemia French Intergroup MRD Flow Network

Blood (2024) 144 (Supplement 1): 226.

https://doi.org/10.1182/blood-2024-205457

Published: 2024

Journal Articles

Combination Chemotherapy in Patients with Newly Diagnosed Blastic Plasmacytoid Dendritic Cell Neoplasms (BPDCN): First Results of a Prospective French Trial (LpDessai)

Blood (2023) 142 (Supplement 1): 1516.

https://doi.org/10.1182/blood-2023-173379

Published: 2023

Journal Articles

AML MRD By Multiparameter Flow Cytometry Using Laip/Dfn and LSC: Methodological Aspects in a Multicentric Study of the French-Flow MRD AML ALFA Network

Blood (2022) 140 (Supplement 1): 6279–6281.

https://doi.org/10.1182/blood-2022-169696

Published: 2022

Journal Articles

Sub-Cutaneous Administration of Rituximab Triggers a Pro-Phagocytic Phenotype of Monocytic Compartment in Low-Tumor Burden Follicular Lymphoma Patients Included in the Flirt Clinical Trial, a Lysa Study

Mikael Roussel, Cedric Menard, Delphine Rossille, Julien Saint-Vanne, Joelle Dulong, Emmanuel Bachy, Herve Tilly, Delphine Pranger, Franck Morschhauser, Luc Xerri, Guillaume Cartron, Karin Tarte

Blood (2022) 140 (Supplement 1): 6462–6463.

https://doi.org/10.1182/blood-2022-169295

Published: 2022

Journal Articles

Chromatin Accessibility Profiling to Increase Diagnostic Accuracy and Refine Cell-of-Origin Classification of Mature T-Cell Lymphomas

Blood (2021) 138 (Supplement 1): 809.

https://doi.org/10.1182/blood-2021-150034

Published: 2021

Journal Articles

Assessment of Circulating Tumor DNA in Newly Diagnosed DLBCL Patients Randomly Treated By R-CHOP or R-High Dose Chemotherapy Plus Autologous Stem Cell Support

Fabienne Desmots-Loyer, Delphine Rossille, Mikael Roussel, Steven Le Gouill, Thierry Lamy, Noel Milpied, Thierry Fest

Blood (2021) 138 (Supplement 1): 3501.

https://doi.org/10.1182/blood-2021-145035

Published: 2021

Journal Articles

Kte-X19 in Relapsed or Refractory Mantle-Cell Lymphoma, a "Real-Life" Study from the Descar-T Registry and Lysa Group

Blood (2021) 138 (Supplement 1): 743.

https://doi.org/10.1182/blood-2021-148626

Published: 2021

Journal Articles

Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells

Cédric Pastoret, Fabienne Desmots, Gaëlle Drillet, Simon Le Gallou, Marie-Laure Boulland, Alexia Thannberger, Anne-Violaine Doncker, Véronique Salaun, Gandhi Laurent Damaj, Richard Veyrat-Masson, Olivier Tournilhac, Aline Moignet, Céline Pangault, Mikaël Roussel, Thierry Fest, Thierry Lamy

Blood (2021) 137 (23): 3237–3250.

https://doi.org/10.1182/blood.2020006721

Published: 2021

Includes: Supplemental data

Journal Articles

Pan-HDAC Inhibitors May Restore PRDM1 Expression in Follicular Lymphoma

Thierry Fest, Fabienne Desmots-Loyer, Mikael Roussel, MD PhD, Celine Pangault, PhD, Cedric Pastoret, MD, Francisco Llamas-Gutierrez, Eric Guiheneuf, Valérie Camara-clayette, Thierry Lamy, Pr, MD PhD, Karin Tarte, PhD, Vincent Ribrag, MD

Blood (2018) 132 (Supplement 1): 2848.

https://doi.org/10.1182/blood-2018-99-113269

Published: 2018

Journal Articles

Multicentric Validation of the "Monocyte Assay" for Chronic Myelomonocytic Leukemia Diagnosis By Flow Cytometry

Sihem Tarfi, Véronique Harrivel, MD, Florent Dumezy, MD, Julien Guy, MD, Mikael Roussel, MD PhD, Aguirre Mimoun, MD, Pierre Fenaux, MD PhD, Nicolas Chapuis, PharmD, PhD, Éric Solary, MD PhD, Dorothée Selimoglu-Buet, PhD, Orianne Wagner Ballon

Blood (2017) 130 (Supplement 1): 4273.

https://doi.org/10.1182/blood.V130.Suppl_1.4273.4273

Published: 2017

Journal Articles

Expression of S100A9 in Bone Marrow Cells Differentiates Refractory Cytopenia with Multilineage Dysplasia (RCMD) from Refractory Anemia with Excess Blasts (RAEB) and Acute Myeloid Leukemia (AML)

Paul Brent Ferrell, Jr., MD, Caroline R. Maier, BS, Mikael Roussel, MD PhD, Michael R. Savona, MD, Jonathan Michael Irish, PhD

Blood (2016) 128 (22): 4303.

https://doi.org/10.1182/blood.V128.22.4303.4303

Published: 2016

Journal Articles

T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells

Imane Azzaoui, Fabrice Uhel, Delphine Rossille, Celine Pangault, Joelle Dulong, Jerome Le Priol, Thierry Lamy, Roch Houot, Steven Le Gouill, Guillaume Cartron, Pascal Godmer, Krimo Bouabdallah, Noel Milpied, Gandhi Damaj, Karin Tarte, Thierry Fest, Mikael Roussel

Blood (2016) 128 (8): 1081–1092.

https://doi.org/10.1182/blood-2015-08-662783

Published: 2016

Includes: Supplemental data

Journal Articles

T-Cell Defect in Diffuse Large B-Cell Lymphomas Involves Expansion of Myeloid Derived Suppressor Cells Expressing IL-10, PD-L1, and S100A12

Imane Azzaoui, PhD, Fabrice Uhel, MD, Delphine Rossille, PhD, Céline Pangault, PharmD PhD, Joelle Dulong, Jerome Le Priol, PhD, Thierry Lamy, MDPhD, Roch Houot, MD PhD, Steven Le Gouill, MD PhD, Guillaume Cartron, MD PhD, Pascal Godmer, MD, Krimo Bouabdallah, MD, Noel Milpied, MD PhD, Karin Tarte, PhD, Thierry Fest, MD PhD, Mikael Roussel, MD PhD

Blood (2015) 126 (23): 1478.

https://doi.org/10.1182/blood.V126.23.1478.1478

Published: 2015

Journal Articles

Biological Description of 109 Cases of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) from the French Network of BPDCN

Eve Poret, Fanny Angelot Delettre, Sabeha Biichle, Anne Roogy, Louis Benazet, Maider Pagadoy, Chrystelle Vidal, Franck Leroux, Véronique Harrivel, Christophe Ferrand, PhD, Veronique Salaun, Zehaira Benseddik, Julien Guy, Marie Christine Jacob, Christophe Roumier, Jean Feuillard, Liliana Vila, Lucile Baseggio, Adriana Plesa, Christine Arnoulet, B Benet, Bernard Drenou, MD, Veronique Latger Cannard, Marie-Christine Bene, MD, Michel Ticchioni, Daniel Lusina, Valerie Bardet, Magalie LE Garff Tavernier, Elizabeth Macintyre, MD PhD, Vahid Asnafi, MDPhD, Maria Elena Noguera, Sabrina Bouyer, Carine Lecoq Lafon, Mikael Roussel, MD PhD, Fabrice Jardin, Francoise Solly, MD, Lydia Campos, MD PhD, Anne Galoisy, Anne Arnaud, Sylvie Daliphard, Franck Genevieve, MD PhD, Romaric Lacroix, Françoise Schillinger, Estelle Seilles, Delphine Binda, Eric Deconinck, Philippe Saas, PhD, Francine Garnache Ottou, PhD

Blood (2015) 126 (23): 3812.

https://doi.org/10.1182/blood.V126.23.3812.3812

Published: 2015

Journal Articles

Identification of Previously Unrecognized CD1d-Restricted Peripheral T Cell Lymphomas (PTCLs) in Mouse and Human Reveals Blocking Anti-CD1d Monoclonal Antibodies As a New Therapeutic Possibility in PTCLs

Blood (2014) 124 (21): 4485.

https://doi.org/10.1182/blood.V124.21.4485.4485

Published: 2014

Journal Articles

Validation of Elevated Blood Soluble PD-L1 As an Independent Prognostic Marker in Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Thierry Fest, MD PhD, James R Cerhan, MD PhD, Maher K Gandhi, PhD FRACP, FRCPath, FRCP, Imane Azzaoui, PhD, Pauline Crooks, BSc, Matthew J Maurer, MS, Noel Milpied, MD PhD, Mark S Hertzberg, MBBS PhDFRACP FRCPA, Thierry Lamy, MD PhD, Stephen M. Ansell, MD PhD, Susan L Slager, PhD, Andrew L. Feldman, MD, Mikael Roussel, MD PhD, Thomas M Habermann, MD, Herve Ghesquieres, MD PhD, Thomas E. Witzig, MD, Brian K Link, MD, Delphine Rossille, PhD

Blood (2014) 124 (21): 2998.

https://doi.org/10.1182/blood.V124.21.2998.2998

Published: 2014

Journal Articles

Diffuse Large B Cell Lymphoma (DLBCL) infiltrating T Cells Display an Activated and Exhausted Status and Are Inhibited By Ligands of Cosignaling Receptors Including PD-L1, PD-L2 and CD80 Expressed By Most DLBCL in Situ

Daniel Olive, MD, PhD, Kieu Suong Le, Mikael Roussel, MD PhD, Florence Broussais, MD, Imane Azzaoui, PhD, Delphine Rossille, Reda Bouabdallah, MD, Thierry Fest, MD PhD, Luc Xerri, Thierry Lamy, MD PhD, Céline Pangault, PharmD, PhD

Blood (2014) 124 (21): 1665.

https://doi.org/10.1182/blood.V124.21.1665.1665

Published: 2014

Journal Articles

Follicular Lymphoma Cell Niche: Identification of a Preeminent IL-4-Dependent T FH - B Cell Axis.

Karin Tarte, PhD, Pangault Celine, PhD, Patricia Ame-Thomas, PhD, Philippe Ruminy, PhD, Delphine Rossille, Gersende Caron, PhD, Maryse Bahia, John De Vos, MD, PhD, Mikael Roussel, MD, PhD, Celine Monvoisin, Thierry Lamy, MD, PhD, Philippe Gaulard, MD, Herve Tilly, MD, Thierry Fest, MD, PhD

Blood (2009) 114 (22): 757.

https://doi.org/10.1182/blood.V114.22.757.757

Published: 2009

Journal Articles

WBC Differential by Flow Cytometry: The First Routine Application in a Large University Hospital Clinical Laboratory.

Mikael Roussel, MD, Cyrille Benard, MT, Béatrice Ly Sunnaram, Danielle Gerard, MT, Jean Feuillard, MD, PhD, Thierry Fest, MD, PhD

Blood (2007) 110 (11): 3845.

https://doi.org/10.1182/blood.V110.11.3845.3845

Published: 2007

NARROW

Prospective, Multicentric, Phase II Randomized Controlled Trial Comparing the Efficacy and Toxicity of Methotrexate to Cyclophosphamide in Large Granular Lymphocyte Leukemia: A French National Study (NCT01976182)

Flow MRD Monitoring Combining Laip/Dfn and CD34+CD38- LSCs Is a Strong Predictor of Outcome in Adult AML Independently of the ELN-2022 Risk: First Results from the Multicentric Acute Leukemia French Intergroup MRD Flow Network

Combination Chemotherapy in Patients with Newly Diagnosed Blastic Plasmacytoid Dendritic Cell Neoplasms (BPDCN): First Results of a Prospective French Trial (LpDessai)

AML MRD By Multiparameter Flow Cytometry Using Laip/Dfn and LSC: Methodological Aspects in a Multicentric Study of the French-Flow MRD AML ALFA Network

Sub-Cutaneous Administration of Rituximab Triggers a Pro-Phagocytic Phenotype of Monocytic Compartment in Low-Tumor Burden Follicular Lymphoma Patients Included in the Flirt Clinical Trial, a Lysa Study

Chromatin Accessibility Profiling to Increase Diagnostic Accuracy and Refine Cell-of-Origin Classification of Mature T-Cell Lymphomas

Assessment of Circulating Tumor DNA in Newly Diagnosed DLBCL Patients Randomly Treated By R-CHOP or R-High Dose Chemotherapy Plus Autologous Stem Cell Support

Kte-X19 in Relapsed or Refractory Mantle-Cell Lymphoma, a "Real-Life" Study from the Descar-T Registry and Lysa Group

Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells

Pan-HDAC Inhibitors May Restore PRDM1 Expression in Follicular Lymphoma

Multicentric Validation of the "Monocyte Assay" for Chronic Myelomonocytic Leukemia Diagnosis By Flow Cytometry

Expression of S100A9 in Bone Marrow Cells Differentiates Refractory Cytopenia with Multilineage Dysplasia (RCMD) from Refractory Anemia with Excess Blasts (RAEB) and Acute Myeloid Leukemia (AML)

T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells

T-Cell Defect in Diffuse Large B-Cell Lymphomas Involves Expansion of Myeloid Derived Suppressor Cells Expressing IL-10, PD-L1, and S100A12

Biological Description of 109 Cases of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) from the French Network of BPDCN

Identification of Previously Unrecognized CD1d-Restricted Peripheral T Cell Lymphomas (PTCLs) in Mouse and Human Reveals Blocking Anti-CD1d Monoclonal Antibodies As a New Therapeutic Possibility in PTCLs

Validation of Elevated Blood Soluble PD-L1 As an Independent Prognostic Marker in Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Diffuse Large B Cell Lymphoma (DLBCL) infiltrating T Cells Display an Activated and Exhausted Status and Are Inhibited By Ligands of Cosignaling Receptors Including PD-L1, PD-L2 and CD80 Expressed By Most DLBCL in Situ

Follicular Lymphoma Cell Niche: Identification of a Preeminent IL-4-Dependent T FH - B Cell Axis.

WBC Differential by Flow Cytometry: The First Routine Application in a Large University Hospital Clinical Laboratory.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only